These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 9281393)
1. Anti-MIP-1alpha and anti-RANTES antibodies: new allies of HIV-1? Kissler S; Süsal C; Opelz G Clin Immunol Immunopathol; 1997 Sep; 84(3):338-41. PubMed ID: 9281393 [TBL] [Abstract][Full Text] [Related]
2. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha. Maeda Y; Foda M; Matsushita S; Harada S J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351 [TBL] [Abstract][Full Text] [Related]
3. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377 [TBL] [Abstract][Full Text] [Related]
4. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Scarlatti G; Tresoldi E; Björndal A; Fredriksson R; Colognesi C; Deng HK; Malnati MS; Plebani A; Siccardi AG; Littman DR; Fenyö EM; Lusso P Nat Med; 1997 Nov; 3(11):1259-65. PubMed ID: 9359702 [TBL] [Abstract][Full Text] [Related]
5. Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta. Annunziato F; Galli G; Nappi F; Cosmi L; Manetti R; Maggi E; Ensoli B; Romagnani S Blood; 2000 Feb; 95(4):1167-74. PubMed ID: 10666186 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954 [TBL] [Abstract][Full Text] [Related]
7. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. Saha K; Bentsman G; Chess L; Volsky DJ J Virol; 1998 Jan; 72(1):876-81. PubMed ID: 9420304 [TBL] [Abstract][Full Text] [Related]
8. Role of MIP-1beta and RANTES in HIV-1 infection of microglia: inhibition of infection and induction by IFNbeta. Kitai R; Zhao ML; Zhang N; Hua LL; Lee SC J Neuroimmunol; 2000 Oct; 110(1-2):230-9. PubMed ID: 11024554 [TBL] [Abstract][Full Text] [Related]
9. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. Trkola A; Paxton WA; Monard SP; Hoxie JA; Siani MA; Thompson DA; Wu L; Mackay CR; Horuk R; Moore JP J Virol; 1998 Jan; 72(1):396-404. PubMed ID: 9420238 [TBL] [Abstract][Full Text] [Related]
10. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines. Dolei A; Biolchini A; Serra C; Curreli S; Gomes E; Dianzani F AIDS; 1998 Jan; 12(2):183-90. PubMed ID: 9468367 [TBL] [Abstract][Full Text] [Related]
11. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers. Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989 [TBL] [Abstract][Full Text] [Related]
12. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding. Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of M-tropic HIV-1 infection by the fd phage-gene 3 protein with MIP-1alpha-binding activity. Meta A; Torigoe N; Ito Y; Arakaki R; Nakashima H; Sugimura K Mol Immunol; 1999 Dec; 36(18):1249-54. PubMed ID: 10684964 [TBL] [Abstract][Full Text] [Related]
14. Bovine immunodeficiency virus expression in vitro is reduced in the presence of beta-chemokines, MIP-1alpha, MIP-1beta and RANTES. Wright SM; Mleczko A; Coats KS Vet Res Commun; 2002 Apr; 26(3):239-50. PubMed ID: 12090295 [TBL] [Abstract][Full Text] [Related]
15. Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire. Jennes W; Sawadogo S; Koblavi-Dème S; Vuylsteke B; Maurice C; Roels TH; Chorba T; Nkengasong JN; Kestens L AIDS Res Hum Retroviruses; 2002 Feb; 18(3):171-7. PubMed ID: 11839151 [TBL] [Abstract][Full Text] [Related]
16. CCR5 genotype and plasma beta-chemokine concentration of Brazilian HIV-infected individuals. Mikawa AY; Tagliavini SA; Costa PI Braz J Med Biol Res; 2002 Nov; 35(11):1333-7. PubMed ID: 12426633 [TBL] [Abstract][Full Text] [Related]
17. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines. Margolis LB; Glushakova S; Grivel JC; Murphy PM J Clin Invest; 1998 May; 101(9):1876-80. PubMed ID: 9576751 [TBL] [Abstract][Full Text] [Related]
18. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4. Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages. Capobianchi MR; Abbate I; Antonelli G; Turriziani O; Dolei A; Dianzani F AIDS Res Hum Retroviruses; 1998 Feb; 14(3):233-40. PubMed ID: 9491913 [TBL] [Abstract][Full Text] [Related]
20. Lack of good correlation of serum CC-chemokine levels with human immunodeficiency virus-1 disease stage and response to treatment. Ye P; Kazanjian P; Kunkel SL; Kirschner DE J Lab Clin Med; 2004 May; 143(5):310-9. PubMed ID: 15122175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]